Thornton & Ross Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Thornton & Ross Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3410
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products comprise cough syrups, sprays and disinfectants, antiseptic creams, baby products, pain relievers, skin care creams, antacids and chickenpox medicines. The company also offers drugs for indigestion problem. It sells its products through a network of distributors across the UK. Thornton & Ross is headquartered in Huddersfield, West Yorkshire, the UK.

Thornton & Ross Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Thornton & Ross Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Thornton & Ross Acquires Rights for Flexitol from LaCorium Health for USD17 Million 10
Licensing Agreements 11
Thornton & Ross Enters into Licensing Agreement with Futura Medical 11
Acquisition 12
Stada Arzneimittel Completes Acquisition Of Thornton & Ross, OTC Drug Maker, For US$339 Million 12
Thornton & Ross Ltd – Key Competitors 14
Thornton & Ross Ltd – Key Employees 15
Thornton & Ross Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Thornton & Ross Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Thornton & Ross Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Thornton & Ross Acquires Rights for Flexitol from LaCorium Health for USD17 Million 10
Thornton & Ross Enters into Licensing Agreement with Futura Medical 11
Stada Arzneimittel Completes Acquisition Of Thornton & Ross, OTC Drug Maker, For US$339 Million 12
Thornton & Ross Ltd, Key Competitors 14
Thornton & Ross Ltd, Key Employees 15
Thornton & Ross Ltd, Subsidiaries 16

List of Figures
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Thornton & Ross Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dongfang Electric Corporation Ltd (1072):企業の財務・戦略的SWOT分析
    Dongfang Electric Corporation Ltd (1072) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Kerr Corp:企業の戦略的SWOT分析
    Kerr Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Banco Angolano de Investimentos, SA:企業の戦略・SWOT・財務分析
    Banco Angolano de Investimentos, SA - Strategy, SWOT and Corporate Finance Report Summary Banco Angolano de Investimentos, SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Occidental Chemical Corporation:企業の戦略的SWOT分析
    Occidental Chemical Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • KBC Group NV:企業のM&A・事業提携・投資動向
    KBC Group NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KBC Group NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Shanghai Pharmaceutical Co Ltd (601607):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic a …
  • TE Connectivity Ltd.:企業の戦略・SWOT・財務情報
    TE Connectivity Ltd. - Strategy, SWOT and Corporate Finance Report Summary TE Connectivity Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Etihad Aviation Group PJSC:企業の戦略・SWOT・財務情報
    Etihad Aviation Group PJSC - Strategy, SWOT and Corporate Finance Report Summary Etihad Aviation Group PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Owlstone Medical Ltd:企業の製品パイプライン分析2018
    Summary Owlstone Medical Ltd (Owlstone Medical), formerly Tiger Dawn Ltd, is a diagnostic company. The company develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It offers FAIMS Technology for medical applications; Lonestar for disease biomarker detect …
  • Ontario Power Generation Inc-エネルギー分野:企業M&A・提携分析
    Summary Ontario Power Generation Inc. (OPG) is an electricity generating company, fully owned by the Government of Ontario. It carries out the generation and sale of electricity in Ontario. The company generates electricity by utilizing various sources of energy including nuclear, hydroelectric, bio …
  • The Scoular Company:戦略・SWOT・企業財務分析
    The Scoular Company - Strategy, SWOT and Corporate Finance Report Summary The Scoular Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析
    Vaxart Inc (VXRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hindustan Petroleum Corp Ltd (HINDPETRO):企業の財務・戦略的SWOT分析
    Hindustan Petroleum Corp Ltd (HINDPETRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Acuity Brands, Inc.:戦略・SWOT・企業財務分析
    Acuity Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary Acuity Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CALBEE, Inc. (2229):企業の財務・戦略的SWOT分析
    CALBEE, Inc. (2229) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Correvio Pharma Corp (COM):製薬・医療:M&Aディール及び事業提携情報
    Summary Correvio Pharma Corp(Correvio) formerly known as Cardiome Pharma Corp, is a specialty pharmaceutical company, which develops and commercializes therapies for the treatment and prevention of cardiovascular diseases. The company’s product portfolio includes two marketed products: Brinavess, fo …
  • Gas Malaysia Bhd (GASMSIA):企業の財務・戦略的SWOT分析
    Summary Gas Malaysia Bhd (Gas Malaysia) markets and distributes natural gas and liquefied petroleum gas (LPG). The company provides energy solutions which include power generation system with heat recovery such as power and combined heat; and alternative gas distribution such as virtual pipeline. It …
  • B. Braun Melsungen AG:戦略・SWOT・企業財務分析
    B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report Summary B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alligator Bioscience AB (ATORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Alligator Bioscience AB (Alligator Bioscience) is a clinical-stage biotechnology company that discovers and develops antibody based pharmaceuticals for the treatment of cancer. The company’s pipeline products include ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527. The ADC-1013, currently und …
  • Piramal Enterprises Ltd (PEL):企業の財務・戦略的SWOT分析
    Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆